These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Feeding the critically ill obese patient: a systematic review protocol. Secombe P; Harley S; Chapman M; Aromataris E JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286 [TBL] [Abstract][Full Text] [Related]
4. Overweight, Obesity, and CVD Risk: a Focus on Visceral/Ectopic Fat. Chartrand DJ; Murphy-Després A; Alméras N; Lemieux I; Larose E; Després JP Curr Atheroscler Rep; 2022 Apr; 24(4):185-195. PubMed ID: 35235165 [TBL] [Abstract][Full Text] [Related]
5. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review. Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152 [TBL] [Abstract][Full Text] [Related]
6. Targeting abdominal obesity in cardiology: can we be effective? Poirier P Can J Cardiol; 2008 Sep; 24 Suppl D(Suppl D):13D-17D. PubMed ID: 18787731 [TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular sequelae and risks of obesity]. Silberbauer K Acta Med Austriaca; 1998; 25(4-5):133-5. PubMed ID: 9879387 [TBL] [Abstract][Full Text] [Related]
8. The obesity epidemic and its cardiovascular consequences. Behn A; Ur E Curr Opin Cardiol; 2006 Jul; 21(4):353-60. PubMed ID: 16755205 [TBL] [Abstract][Full Text] [Related]
10. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial. Neeland IJ; Marso SP; Ayers CR; Lewis B; Oslica R; Francis W; Rodder S; Pandey A; Joshi PH Lancet Diabetes Endocrinol; 2021 Sep; 9(9):595-605. PubMed ID: 34358471 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance: the link between obesity and cardiovascular disease. Reaven GM Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697 [TBL] [Abstract][Full Text] [Related]
13. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Stefan N Lancet Diabetes Endocrinol; 2020 Jul; 8(7):616-627. PubMed ID: 32559477 [TBL] [Abstract][Full Text] [Related]
14. [Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics]. Podzolkov VI; Bragina AE; Osadchiy KK; Rodionova YN; Djafarova ZB; Khalenyan MH; Dishkaya SO Ter Arkh; 2022 Oct; 94(9):1072-1077. PubMed ID: 36286758 [TBL] [Abstract][Full Text] [Related]
18. Adipose tissue: a mediator of cardiovascular risk. Sharma AM Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S5-7. PubMed ID: 12457291 [TBL] [Abstract][Full Text] [Related]
19. The obese patient with diabetes mellitus: from research targets to treatment options. Sharma AM Am J Med; 2006 May; 119(5 Suppl 1):S17-23. PubMed ID: 16563943 [TBL] [Abstract][Full Text] [Related]
20. Adipokines at the crossroad between obesity and cardiovascular disease. Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]